1. AB0226 Decline in anti-ccp and rheumatoid factor levels in patients with early rheumatoid arthritis after 2 years of treatment with intensive combination strategies, including prednisolone: the cobra-light trial. (12th June 2018) Authors: Folmo, H.D.; ter Wee, M.M.; den Uyl, D.; Konijn, N.P.; Kerstens, P.J.; Voskuyl, A.E.; van Schaardenburg, D.; Nurmohamed, M.T.; Boers, M.; Lems, W.F. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 1297 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. FRI0076 Low Disease Activity or DAS-Remission as Treatment Target in Early Rheumatoid Arthritis Patients. (15th July 2016) Authors: Akdemir, G.; Markusse, I.M.; Schouffoer, A.A.; de Sonnaville, P.B.; Grillet, B.A.; Kerstens, P.J.; Lems, W.F.; Huizinga, T.W.; Allaart, C.F. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 454 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. FRI0120 Prevalence and predictors of vertebral fractures after 5 years of disease activity steered treatment in patients with early active rheumatoid arthritis. (23rd January 2014) Authors: Dirven, L.; van den Broek, M.; van Groenendael, J.H.; de Beus, W.M.; Kerstens, P.J.; Huizinga, T.W.; Allaart, C.F.; Lems, W.F. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 351 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. OP0151 Cobra-light therapy is clinically non-inferior to original cobra therapy in the treatment of early rheumatoid arthritis. (23rd January 2014) Authors: den Uyl, D.; ter Wee, M.M.; Boers, M.; Voskuyl, A.E.; Kerstens, P.J.; Nurmohamed, M.T.; Raterman, H.G.; van Schaardenburg, D.; van Dillen, N.; Dijkmans, B.A.; Lems, W.F. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 104 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. THU0141 Long-term effects on bone mineral density after four years of treatment with two intensive combination strategies, including initially high dose prednisolone, in early rheumatoid arthritispatients: the cobra-light trial. (12th June 2018) Authors: Lucassen, M.J.; ter Wee, M.M.; den Uyl, D.; Konijn, N.P.; Nurmohamed, M.T.; van Schaardenburg, D.; Kerstens, P.J.; Bultink, I.E.; Van Tuyl, L.H.; Boers, M.; Lems, W.F. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 290 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Tumor necrosis factor-inhibitor treatment duration is associated with lower risk of hand osteoarthritis progression in patients with recent-onset rheumatoid arthritis after 10-year follow-up. (April 2018) Authors: Loef, M.; Kroon, F.P.; Bergstra, S.A.; van der Pol, J.A.; Lems, W.F.; Kerstens, P.J.; Allaart, C.F.; Kloppenburg, M. Journal: Osteoarthritis and cartilage Issue: Volume 26(2018)Supplement 1 Page Start: S300 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗